Wearable neuromodulation to help bowel symptoms after spinal cord injury
Official title: An Early Feasibility Study of Using the AccelBand, a Leg-worn Transcutaneous Neuromodulation (TNM) Device, for Neurogenic Bowel Dysfunction (NBD) in People With Spinal Cord Injury (SCI)
Run by University of Michigan · NCT07171489 · Data updated 2026-11-12
This study tests a wearable device that uses transcutaneous neuromodulation to see if it can lessen neurogenic bowel dysfunction in people with spinal cord injury, compared to a sham treatment.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 100 (estimated) |
| Sponsor | University of Michigan Academic / other |
| Locations | 1 site (Ann Arbor, Michigan) |
| Status | Recruiting |
| Started | July 2026 |
| Main results expected | November 2029 |
| Study ends | November 2029 |
| Registry record updated | July 6, 2026 |
| Trial ID | NCT07171489 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults with traumatic or non-traumatic SCI above T12, AIS B/C/D with chronic (>6 months) SCI and neurogenic bowel dysfunction who can consent.
✕Probably not a fit
Patients with certain medical comorbidities, implanted electrical devices, or conditions excluding participation may not experience benefit from this therapy.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This interventional study examines whether a wearable transcutaneous neuromodulation device can reduce constipation symptoms linked to neurogenic bowel dysfunction in individuals with spinal cord injury. Participants are randomized to receive TNM at a sham point, TNM at a leg point, or an open-label leg-point TNM, with outcomes comparing baseline to post-therapy. The device aims to improve autonomic function and bowel symptoms, using standardized questionnaires and anorectal testing to assess results. Eligible participants include adults with SCI above T12, with chronic SCI and documented NBD, who consent to participate. Exclusion criteria screen for cognitive impairment, major GI surgeries (beyond a few common procedures), diabetes, psychiatric illness, substance abuse, implanted electrical devices, opioid use, pregnancy, active inflammatory bowel disease, ventilator dependence, or severe autonomic dysreflexia.
Why it matters
Potential benefit: If successful, participants could experience improved bowel function and quality of life related to neurogenic bowel dysfunction after spinal cord injury.
How similar studies have gone: Previous studies in neuromodulation approaches for bowel function have shown mixed but promising signals, making this approach plausible but not yet proven.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Traumatic or non-traumatic spinal cord injury (SCI) * SCI level above the twelfth thoracic vertebra (T12) * SCI classified as Sensory Incomplete (AIS B), C, or D * Post-SCI time ≥ 6 months; * Neurogenic bowel dysfunction (NBD) as a result of SCI * Willing to sign the informed consent form Exclusion Criteria: * Significant cognitive impairment, impeding the ability to provide informed consent or complete the questionnaire * Prior gastrointestinal surgeries other than uncomplicated appendectomies, cholecystectomy or cesarean sections * Known diagnosis of diabetes mellitus * Known current or past severe significant psychiatric disorder * Known current substance abuse * Implanted medical devices for electrical stimulation (e.g. cardiac pacemaker) * Taking opioid medications on a regular daily basis * Currently pregnant or actively planning a pregnancy * Active inflammatory bowel disease * Ventilator dependency * Severe autonomic dysreflexia * No preservation of the sacral spinal reflexes: bulbocavernosus, patella, or Achilles * Complete absence of sensation in the leg (since it is needed for calibrating the TNM intensity)
Where it's running
-
University of Michigan
Ann Arbor, Michigan, United States Recruiting
Study contacts
- Principal investigator: Gianna Rodriguez, MD — University of Michigan
- Study coordinator: Caitlyn Fisher
- Email: fishercj@med.umich.edu
- Phone: 734-998-7285
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Transcutaneous spinal cord stimulation with 4-aminopyridine and intensive rehab for chronic spinal cord injury
This pilot study tests whether combining noninvasive spinal stimulation, dalfampridine, and rigorous rehab is safe and feasible for adults with chronic spinal cord injury and whether it can help improve movement and walking.
-
NG004 for incomplete cervical spinal cord injury
This trial tests NG004 versus placebo to see if it is safe and helps motor function and daily life in adults with acute incomplete cervical spinal cord injury.
-
Robot-assisted training for arm and leg movement after stroke or injury
This study tests whether adding ZEPU-AI robotic training to usual therapy is safe and helps adults with arm or leg movement problems from stroke, spinal cord injury, brain injury, or orthopedic conditions.
-
ZEPU-AI3 Lower Limb Feedback Training and Evaluation Robot in Rehab
This pilot trial tests whether adding the ZEPU-AI3 robotic leg training with real-time feedback to standard rehab helps adults with lower limb motor problems from stroke, spinal cord injury, or similar conditions.
-
Combined magnetic stimulation and ultrasound for detrusor overactivity in spinal cord injury
This study tests whether using high-frequency sacral nerve stimulation together with bladder-directed ultrasound can reduce involuntary bladder contractions and improve bladder function in people with spinal cord injury.
-
Hybrid HIIT-FES cycling program for people with spinal cord injury
This study tests a hybrid exercise program that combines functional electrical stimulation cycling with voluntary arm work to improve health in adults with spinal cord injury.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.